SIStockInvestingSI.com

NASDAQ · ISRG · Medical Instruments & Supplies

Intuitive Surgical (ISRG) stock analysis

$428.12−2.26%Data as of Oct 21, 2026
  • ISRG gained 6.5% over the past month versus 0.0% for the S&P 500, ranking 137th of 497 S&P 500 stocks.
  • Over 12 months it returned −6.6%, 22.4 points behind the S&P 500, and trades 27.8% below its 52-week high.
  • In the last 30 days 1 analyst raised earnings estimates and 1 cut; forward EPS moved +0.2% (+0.9% over 90 days).
  • It sits in the Surgical robotics & orthopaedics segment of the Healthcare Value Chain, where the 1-month median return is +7.5%.
  • The daily chart reads Intermediate uptrend · Upside breakout (since Oct 16, 2026).
Market cap$151.2B
12-month return−6.6%
Forward P/E35.3×
Mean target vs price+11.8%

One-year price with 50- and 200-day averages

Open in Hub
353426499572JanAprJulOct
428.1250-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

ISRG+6.5%
Sector median−8.7%
S&P 5000.0%
ISRG+28.9%
Sector median−5.4%
S&P 500+4.7%
ISRG−11.5%
Sector median−1.5%
S&P 500+8.7%
ISRG−6.6%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 500137 / 497
1-month rank in the Nasdaq 10032 / 100
3-month rank in its sector · Healthcare92 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Intermediate uptrend · Upside breakoutConfirmed

Holding since Oct 16, 2026

  • Close above EMA20 above EMA50
  • EMA50 rose over the last ten sessions
  • Confirmed swing highs and lows are rising
  • Volume exceeds 1.5× the prior 20-session average; supporting evidence only
  • Intermediate and long-term directions differ
This pattern on this stock

86 occurrences in 10 years. The median move over the next 20 sessions was +2.0%, positive 64% of the time, against +2.1% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$12.12
30-day change+0.2%
90-day change+0.9%
Mean target$478.53 +11.8%
Raised (30d) 1Cut (30d) 1

30 analysts cover the stock

Fundamental shape vs peers

Six dimensions on fixed scales. The filled shape is the company; the outline is the peer average.

Open the full Radar with every ratio
ValuationRevisionsMomentumGrowthCashProfit

Ahead of peersMomentum

Behind peersValuation

PeersBDX · MDLN · RMD · ALC

Where it sits in the supply chain

Healthcare Value Chain · Drugs & devices

Explore the full chain map in Hub
Its segment
Surgical robotics & orthopaedics+7.5%
ISRG+6.5%1 monthSYK+8.5%1 month

Elective procedure volumes drive demand; strong volumes help hospitals and device makers and raise insurers' claims.

Sells into
Hospitals & care delivery+8.4%
HCA+4.9%1 monthUNH+11.8%1 month

Also on: Medtech, Diagnostics & Care

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−44.0%
Volatility, 60D31.2%
From 52-week high−27.8%
From 52-week low+28.9%
Trailing P/E49.1×
Forward P/E35.3×
SYKStrykerUNHUnitedHealth GroupBDXBecton, Dickinson and CompanyRMDResMed Inc.WSTWest Pharmaceutical Services, ISOLVSolventum CorporationBAXBaxter International Inc.COOThe Cooper Companies, Inc.

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗